| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pao And Pfo | Pao And Interim Pfo | Principal Accounting Officer
1 company
Vultaggio Vincent is a Pao And Pfo at Zentalis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $625K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Pao And Pfo | Sell | 40,224 | $2.43 | $97,556.89 | -8.1% | - | - | |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Pao And Interim Pfo | Sell | 2,615 | $1.71 | $4,475.57 | -1.4% | -19.0% | +67.9% | |
| Oct 4, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Principal Accounting Officer | Sell | 1,603 | $3.18 | $5,097.54 | -4.5% | -11.0% | -52.2% |